Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Akamai Technologies, Inc.

7.1% sales growth and 14.79% return on equity

Akamai Technologies, Inc. provides cloud services for delivering, optimizing, and securing content and business applications over the Internet in the United States and internationally.

Akamai Technologies, Inc.’s sales growth this year is expected to be 9.9% and 6.6% for next year.

Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 3.12B for the twelve trailing months.

Akamai Technologies, Inc.’s sales growth for the next quarter is 7.1%. The company’s growth estimates for the ongoing quarter and the next is 6.5% and 7.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.79%.

Volatility

Akamai Technologies, Inc.’s last day, last week, and last month’s average volatility was a positive 0.63%, a negative 0.31%, and a negative 0.03%, respectively.

Akamai Technologies, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.81%, 2.16%, and 1.90%, respectively.

Akamai Technologies, Inc.’s Stock Yearly Top and Bottom Value

Akamai Technologies, Inc.’s stock is valued at $103.46 at 04:22 EST, way under its 52-week high of $120.00 and way above its 52-week low of $75.18.

Akamai Technologies, Inc.’s Moving Average

Akamai Technologies, Inc.’s worth is under its 50-day moving average of $104.52 and under its 200-day moving average of $107.55.

2. Customers Bancorp, Inc

54.1% sales growth and 10.03% return on equity

Customers Bancorp, Inc. operates as the bank holding company for Customers Bank that provides financial products and services to individual consumers, and small and middle market businesses.

Customers Bancorp, Inc’s sales growth this year is expected to be 42.4% and 5.3% for next year.

Year-on-year quarterly revenue growth grew by 35.5%, now sitting on 394.21M for the twelve trailing months.

Customers Bancorp, Inc’s sales growth for the next quarter is 54.1%. The company’s growth estimates for the current quarter and the next is 77.9% and 8150%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.03%.

Volatility

Customers Bancorp, Inc’s last day, last week, and last month’s average volatility was 4.81%, 3.64%, and 0.70%, respectively.

Customers Bancorp, Inc’s last day, last week, and last month’s high and low average amplitude percentage was 4.18%, 4.82%, and 3.74%, respectively.

Customers Bancorp, Inc’s Stock Yearly Top and Bottom Value

Customers Bancorp, Inc’s stock is valued at $21.58 at 04:22 EST, way below its 52-week high of $24.49 and way above its 52-week low of $8.36.

Customers Bancorp, Inc’s Moving Average

Customers Bancorp, Inc’s worth is way above its 50-day moving average of $18.26 and way above its 200-day moving average of $13.92.

3. Air Products and Chemicals, Inc.

7.5% sales growth and 16.33% return on equity

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide.

Air Products and Chemicals, Inc.’s sales growth this year is anticipated to be 8.1% and 7.4% for next year.

Year-on-year quarterly revenue growth grew by 1.6%, now sitting on 8.86B for the twelve trailing months.

Air Products and Chemicals, Inc.’s sales growth for the next quarter is 7.5%. The company’s growth estimates for the current quarter and the next is 1.9% and 10.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.33%.

Volatility

Air Products and Chemicals, Inc.’s last day, last week, and last month’s average volatility was 2.68%, 1.55%, and 0.28%, respectively.

Air Products and Chemicals, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.72%, 3.24%, and 2.02%, respectively.

Air Products and Chemicals, Inc.’s Stock Yearly Top and Bottom Value

Air Products and Chemicals, Inc.’s stock is valued at $285.29 at 04:22 EST, way under its 52-week high of $327.89 and way higher than its 52-week low of $167.43.

Air Products and Chemicals, Inc.’s Moving Average

Air Products and Chemicals, Inc.’s worth is above its 50-day moving average of $271.94 and higher than its 200-day moving average of $282.15.

4. The ONE Group Hospitality, Inc.

56.4% sales growth and 55.19% return on equity

The ONE Group Hospitality, Inc., a hospitality company, develops, owns, and operates restaurants and lounges worldwide.

The ONE Group Hospitality, Inc.’s sales growth this year is expected to be 22.2% and 35.6% for next year.

Year-on-year quarterly revenue growth grew by 79%, now sitting on 149.15M for the twelve trailing months.

The ONE Group Hospitality, Inc.’s sales growth for the next quarter is 56.4%. The company’s growth estimates for the current quarter and the next is 50% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 55.19%.

Volatility

The ONE Group Hospitality, Inc.’s last day, last week, and last month’s average volatility was a negative 1.00%, a positive 2.54%, and a positive 1.33%, respectively.

The ONE Group Hospitality, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 4.79%, 7.51%, and 6.86%, respectively.

The ONE Group Hospitality, Inc.’s Stock Yearly Top and Bottom Value

The ONE Group Hospitality, Inc.’s stock is valued at $4.02 at 04:22 EST, way below its 52-week high of $4.68 and way above its 52-week low of $0.73.

The ONE Group Hospitality, Inc.’s Moving Average

The ONE Group Hospitality, Inc.’s worth is way higher than its 50-day moving average of $3.39 and way higher than its 200-day moving average of $2.40.

5. Alexion Pharmaceuticals, Inc.

9.5% sales growth and 8.92% return on equity

Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products.

Alexion Pharmaceuticals, Inc.’s sales growth this year is expected to be 20.8% and 9.2% for next year.

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 5.86B for the twelve trailing months.

Alexion Pharmaceuticals, Inc.’s sales growth for the next quarter is 9.5%. The company’s growth estimates for the ongoing quarter and the next is a negative 5.5% and negative -3.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.92%.

Volatility

Alexion Pharmaceuticals, Inc.’s last day, last week, and last month’s average volatility was 1.03%, 0.14%, and 1.49%, respectively.

Alexion Pharmaceuticals, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 0.85%, 1.22%, and 1.47%, respectively.

Alexion Pharmaceuticals, Inc.’s Stock Yearly Top and Bottom Value

Alexion Pharmaceuticals, Inc.’s stock is valued at $157.35 at 04:22 EST, below its 52-week high of $160.03 and way above its 52-week low of $72.67.

Alexion Pharmaceuticals, Inc.’s Moving Average

Alexion Pharmaceuticals, Inc.’s worth is way higher than its 50-day moving average of $140.79 and way above its 200-day moving average of $119.39.

LEAVE A REPLY

Please enter your comment!
Please enter your name here